Chiropractors in Carlyle, IL Accepting Medicare
7 Chiropractors found. Showing 1 - 7
 Clarion Healing Center, Ltd Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 971 Eula Mae Pkwy, Carlyle, IL 62231 Phone: 618-594-3671 Fax: 618-594-8058 |
 Jana Rae Wuebbels, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 971 Eula Mae Pkwy, Carlyle, IL 62231 Phone: 618-594-3671 |
Carlyle Rehab & Pain Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2111 W Lake Dr, Carlyle, IL 62231 Phone: 618-664-4600 |
Med Plus Physical Medicine Chiropractor Medicare: Medicare Enrolled Practice Location: 18209 Eula Mae Pkwy, Carlyle, IL 62231 Phone: 618-594-3671 Fax: 618-594-8058 |
 Dr. Jeffrey A Schatz, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2431 Franklin St, Carlyle, IL 62231 Phone: 618-594-3671 Fax: 618-594-8058 |
Dr. Matthew Palm, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 18209 Eula Mae Pkwy, Carlyle, IL 62231 Phone: 618-594-3671 |
Dr. Brian Scott Walsh, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 18209 Eula Mae Pkwy, Carlyle, IL 62231 Phone: 618-594-3671 Fax: 618-594-3671 |
News Archive
Canada hosts the 12th Annual International Generic Pharmaceutical Alliance Conference
Canada is hosting the 12th Annual International Generic Pharmaceutical Alliance (IGPA) Conference in Montréal from September 30 through October 2, 2009, the first time the event has been held in Canada.
Telemedicine can help pregnant women struggling with opioids
Sarah, a military veteran living on the coast of South Carolina, knew she had a problem. The opioids prescribed for her pain were becoming a headache of their own.
London Health Commission announces winners of community action for health and well-being awards
The winners of the London Health Commission Awards were announced last night at City Hall. The winners were all small community-based organisations.
ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced initial safety and preliminary anti-tumor activity from the FORWARD II expansion cohort assessing mirvetuximab soravtansine in combination with Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab).
› Verified 2 days ago
Chiropractors
Speech-Language Pathologists
Physical Therapists
Occupational Therapists
Optometrists
Audiologists